Report Detail
Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Insights, Forecast to 2025
- RnM3522890 |
- 14 June, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes.
The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market based on company, product type, end user and key regions.
This report studies the global market size of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in these regions.
This research report categorizes the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market by top players/brands, region, type and end user. This report also studies the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Takeda
Eli Lilly
Merck
Novo Nordisk
Bristol-Myers Squibb
Pfizer
AstraZeneca
GlaxoSmithKline
Boehringer Ingelheim
Market size by Product
Nesina
Tradjenta
Onglyza
Januvia
Others
Market size by End User
Type 2 Diabetes
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by Product
- 1.4.2 Nesina
- 1.4.3 Tradjenta
- 1.4.4 Onglyza
- 1.4.5 Januvia
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Growth Rate by End User
- 1.5.2 Type 2 Diabetes
- 1.5.3 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size
- 2.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2014-2025
- 2.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2014-2025
- 2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Growth Rate by Regions
- 2.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Regions
- 2.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers
- 3.1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers
- 3.1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers
- 3.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Ratio (CR5 and HHI)
- 3.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers
- 3.2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers (2014-2019)
- 3.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2014-2019)
- 3.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Manufacturers
- 3.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Base Distribution, Product Types
- 3.4.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Type
- 3.4.3 Date of International Manufacturers Enter into Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Product
- 4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Product
- 4.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Breakdown Data by End User
6 North America
- 6.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries
- 6.1.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries
- 6.1.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Product
- 6.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by End User
7 Europe
- 7.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries
- 7.1.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries
- 7.1.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Product
- 7.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by End User
8 Asia Pacific
- 8.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries
- 8.1.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries
- 8.1.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Product
- 8.3 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by End User
9 Central & South America
- 9.1 Central & South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries
- 9.1.1 Central & South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries
- 9.1.2 Central & South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Product
- 9.3 Central & South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Countries
- 10.1.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries
- 10.1.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Product
- 10.3 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by End User
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Takeda
- 11.2.1 Takeda Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.2.5 Takeda Recent Development
- 11.3 Eli Lilly
- 11.3.1 Eli Lilly Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.3.5 Eli Lilly Recent Development
- 11.4 Merck
- 11.4.1 Merck Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.4.5 Merck Recent Development
- 11.5 Novo Nordisk
- 11.5.1 Novo Nordisk Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.5.5 Novo Nordisk Recent Development
- 11.6 Bristol-Myers Squibb
- 11.6.1 Bristol-Myers Squibb Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.6.5 Bristol-Myers Squibb Recent Development
- 11.7 Pfizer
- 11.7.1 Pfizer Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.7.5 Pfizer Recent Development
- 11.8 AstraZeneca
- 11.8.1 AstraZeneca Company Details
- 11.8.2 Company Business Overview
- 11.8.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.8.5 AstraZeneca Recent Development
- 11.9 GlaxoSmithKline
- 11.9.1 GlaxoSmithKline Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.9.5 GlaxoSmithKline Recent Development
- 11.10 Boehringer Ingelheim
- 11.10.1 Boehringer Ingelheim Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Products Offered
- 11.10.5 Boehringer Ingelheim Recent Development
12 Future Forecast
- 12.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Regions
- 12.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Regions 2019-2025
- 12.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Product
- 12.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Product 2019-2025
- 12.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Product 2019-2025
- 12.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by End User
- 12.4 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast
- 12.5 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast
- 12.6 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast
- 12.7 Central & South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast
- 12.8 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors. Industry analysis & Market Report on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is a syndicated market report, published as Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
